Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000213 · ClinicalTrials.gov registry record · Phase 2
IV Cocaine Abuse: A Laboratory Model - 2
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000213: Completed Phase 2 study, sponsored by New York State Psychiatric Institute.
NCT00000213 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000213, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of fluoxetine maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
Interventions
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1990-04 |
| Est. Completion | 1991-04 |
| Phase | Phase 2 |
What the finished NCT00000213 record still lists
NCT00000213 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fluoxetine is the first listed.
NCT00000213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000213 about?
NCT00000213 is a clinical study titled "IV Cocaine Abuse: A Laboratory Model - 2". The purpose of this study is to evaluate the effects of fluoxetine maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
What is the current status of trial NCT00000213?
This trial is currently completed. It is a Phase 2 study. The study started on 1990-04. Estimated completion is 1991-04.
What interventions are being tested in trial NCT00000213?
The interventions under investigation include: Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00000213?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia